Takeda Expert Says Smoking Key In Actos Plaintiff's Cancer
Law360, Philadelphia (September 29, 2014, 5:34 PM EDT) -- An expert witness for Takeda Pharmaceuticals Co. told a Philadelphia jury on Monday that other risk factors, including age and a history of smoking, are more likely to blame for a Pennsylvania woman's bladder cancer than the diabetes medication Actos.
Mark Schoenberg, a urologic oncologist at the Albert Einstein College of Medicine at Yeshiva University, testified that his review of medical records and scientific literature had led him to conclude that there was no significant link between Actos and instances of bladder cancer, and that plaintiff Frances Wisniewski had a number of other factors putting her at greater risk.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!